(Q53301416)

13 May 2018

title

Radiofluorinated pyrimidine-2,4,6-triones as molecular probes for noninvasive MMP-targeted imaging. (English)

1 reference

13 May 2018

author name string

Hans-Jörg Breyholz

1

1 reference

13 May 2018

Stefan Wagner

2

1 reference

13 May 2018

Andreas Faust

3

1 reference

13 May 2018

Burkhard Riemann

4

1 reference

13 May 2018

Carsten Höltke

5

1 reference

13 May 2018

Sven Hermann

6

1 reference

13 May 2018

Otmar Schober

7

1 reference

13 May 2018

Michael Schäfers

8

1 reference

13 May 2018

Klaus Kopka

9

1 reference

13 May 2018

publication date

1 May 2010

1 reference

13 May 2018

published in

ChemMedChem

1 reference

13 May 2018

volume

5

1 reference

13 May 2018

issue

5

1 reference

13 May 2018

page(s)

777-789

1 reference

13 May 2018

Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000013

Strategies for MMP inhibition in cancer: innovations for the post-trial era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000013

Matrix metalloproteinases in coronary artery disease: clinical and therapeutic implications and pathological significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000013

Extracellular matrix remodelling: the role of matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000013

Matrix metalloproteinases as therapeutic targets in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000013

New functions for the matrix metalloproteinases in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000013

The dynamic extracellular matrix: intervention strategies during heart failure and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000013

Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000013

Scintigraphic imaging of matrix metalloproteinase activity in the arterial wall in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000013

Noninvasive targeted imaging of matrix metalloproteinase activation in a murine model of postinfarction remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000013

Molecular imaging of activated matrix metalloproteinases in vascular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000013

Molecular imaging of matrix metalloproteinase expression in atherosclerotic plaques of mice deficient in apolipoprotein e or low-density-lipoprotein receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000013

Recent advances in MMP inhibitor design

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000013

Matrix metalloproteinase inhibitors: new challenges in the era of post broad-spectrum inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000013

Mechanisms to inhibit matrix metalloproteinase activity: where are we in the development of clinically relevant inhibitors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000013

Pyrimidine-2,4,6-Triones: a new effective and selective class of matrix metalloproteinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000013

The 1.8-A crystal structure of a matrix metalloproteinase 8-barbiturate inhibitor complex reveals a previously unobserved mechanism for collagenase substrate recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000013

Novel 5,5-disubstitutedpyrimidine-2,4,6-triones as selective MMP inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000013

Anti-Invasive, Antitumoral, and Antiangiogenic Efficacy of a Pyrimidine-2,4,6-trione Derivative, an Orally Active and Selective Matrix Metalloproteinases Inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000013

Matrix metalloproteinase inhibitors for cancer therapy:the current situation and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000013

C-5-disubstituted barbiturates as potential molecular probes for noninvasive matrix metalloproteinase imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000013

Synthesis and evaluation of a novel fluorescent photoprobe for imaging matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000013

Fluorescent pirenzepine derivatives as potential bitopic ligands of the human M1 muscarinic receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000013

Effect of pegylation on pharmaceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000013

Pegylation: a novel process for modifying pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000013

Pharmacokinetic consequences of pegylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000013

microPET of tumor integrin alphavbeta3 expression using 18F-labeled PEGylated tetrameric RGD peptide (18F-FPRGD4)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000013

Noninvasive imaging of tumor integrin expression using (18)F-labeled RGD dimer peptide with PEG (4) linkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000013

(68)Ga-labeled cyclic RGD dimers with Gly3 and PEG4 linkers: promising agents for tumor integrin alphavbeta3 PET imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000013

Improving tumor-targeting capability and pharmacokinetics of (99m)Tc-labeled cyclic RGD dimers with PEG(4) linkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000013

Pharmacological properties of hydrophilic and lipophilic derivatives of octreotate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000013

Design, synthesis, and analysis of a polyethelene glycol-modified (PEGylated) small molecule inhibitor of integrin {alpha}4{beta}1 with improved pharmaceutical properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000013

18F-labeled styrylpyridines as PET agents for amyloid plaque imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000013

Click chemistry reactions in medicinal chemistry: applications of the 1,3-dipolar cycloaddition between azides and alkynes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000013

Peptidomimetics via copper-catalyzed azide-alkyne cycloadditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000013

Click chemistry and medicinal chemistry: a case of "cyclo-addiction".

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000013

Click chemistry, a powerful tool for pharmaceutical sciences

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000013

Heterocyclic peptide backbone modifications in an alpha-helical coiled coil

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000013

Click chemistry for (18)F-labeling of RGD peptides and microPET imaging of tumor integrin alphavbeta3 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000013

An admonition when measuring the lipophilicity of radiotracers using counting techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000013

Performance evaluation of the 16-module quad-HIDAC small animal PET camera.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000013

Three-dimensional contour detection of left ventricular myocardium using elastic surfaces.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000013

Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000013

7 January 2021

Vulnerable plaque: the devil is in the details

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000013

7 January 2021

Synthesis and preliminary biological evaluation of new radioiodinated MMP inhibitors for imaging MMP activity in vivo

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000013

7 January 2021

Mutational study of the amino-terminal domain of human tissue inhibitor of metalloproteinases 1 (TIMP-1) locates an inhibitory region for matrix metalloproteinases

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000013

7 January 2021

Stabilization of G-Quadruplex DNA by Highly Selective Ligands via Click Chemistry

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201000013

7 January 2021

Identifiers

DOI

10.1002/CMDC.201000013

1 reference

13 May 2018

1 reference

13 May 2018